Júlia Lenza Goulart
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Júlia Lenza Goulart has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
- Anderson Garcez
Post-Graduate Program in Medical Sciences: Endocrinology, Faculty of Medicine, Federal University of Rio Grande do Sul State, UFRGS, Porto Alegre 90610-264, RS, Brazil
1 shared publication - André Santos Pereira Ramos
Universidade de Rio Verde (Rio Verde). Góias, Brasil
1 shared publication - Carlabianca Cabral de Jesus Canevari
Universidade de Rio Verde
1 shared publication - Elton Brás Camargo Júnior
Universidade de Rio Verde
1 shared publication - Fábio Vieira de Andrade Borges
Faculty of Medical Sciences University of Rio Verde Rio Verde Goiás Brazil
1 shared publication - Heloísa Silva Guerra
Universidade de Rio Verde
1 shared publication
Latest Publications
- Open Access
- 25 September 2026
- Published by Elsevier in Sleep Epidemiology
- Vol. 6
High likelihood of obstructive sleep apnea and associated factors among road freight transport workers in Brazil
- 25 September 2026
- Published by Elsevier in Sleep Epidemiology
- Vol. 6
Open AccessHigh likelihood of obstructive sleep apnea and associated factors among road freight transport workers in Brazil
- Open Access
- 8 November 2023
- Published by Research, Society and Development in Research, Society and Development
- Vol. 12 (12)
Demystifying the results obtained through the use of SGLT-2 inhibitor drugs, used by patients at the Reference Center for Hypertension and Diabetes Rio Verde - Goiás
Introduction: Due to the increase in glucose excretion of renal sodium-glucose cotransporter 2 (ISGLT-2) inhibitors, there is also a reduction in weight through its glycosuric effect. Objective: To analyze the efficacy of ISGLT-2 based on medical records and glycemic levels according to glycated blood glucose; to verify which medications are most prescribed and to observe poor adherence due to side effects in patients of the CRHD in Rio Verde-GO. Methods: A descriptive observational study was carried out using the medical records of diabetic patients treated at the CRHD as the main means of data collection, identifying and comparing laboratory values based on the different pharmacological conducts performed. And manually organize and group the search results on the Excel platform, where they will later be converted into easy-to-view graphs for the public. Results And Discussion: When analyzing the glycated hemoglobin (HbA1c) of the patients before and after the introduction of the ISGLT-2 class, it was noted that 80% obtained a laboratory improvement and 20% a worsening. The results reveal that 80% had an improvement in glycated hemoglobin, as they presented good adherence to the medication and specific and balanced nutrition for their condition. Conclusion: There is an improvement in glycated hemoglobin in most of the patients treated at the CRHD who are users of iSGLT-2, where the most used medication is Forxiga (Dapaglifozin), which is part of the medications of the SUS network.
- 8 November 2023
- Published by Research, Society and Development in Research, Society and Development
- Vol. 12 (12)
Open AccessDemystifying the results obtained through the use of SGLT-2 inhibitor drugs, used by patients at the Reference Center for Hypertension and Diabetes Rio Verde - Goiás
Introduction: Due to the increase in glucose excretion of renal sodium-glucose cotransporter 2 (ISGLT-2) inhibitors, there is also a reduction in weight through its glycosuric effect. Objective: To analyze the efficacy of ISGLT-2 based on medical records and glycemic levels according to glycated blood glucose; to verify which medications are most prescribed and to observe poor adherence due to side effects in patients of the CRHD in Rio Verde-GO. Methods: A descriptive observational study was carried out using the medical records of diabetic patients treated at the CRHD as the main means of data collection, identifying and comparing laboratory values based on the different pharmacological conducts performed. And manually organize and group the search results on the Excel platform, where they will later be converted into easy-to-view graphs for the public. Results And Discussion: When analyzing the glycated hemoglobin (HbA1c) of the patients before and after the introduction of the ISGLT-2 class, it was noted that 80% obtained a laboratory improvement and 20% a worsening. The results reveal that 80% had an improvement in glycated hemoglobin, as they presented good adherence to the medication and specific and balanced nutrition for their condition. Conclusion: There is an improvement in glycated hemoglobin in most of the patients treated at the CRHD who are users of iSGLT-2, where the most used medication is Forxiga (Dapaglifozin), which is part of the medications of the SUS network.
- Open Access
- 4 July 2023
- Published by Escola Bahiana de Medicina e Saude Publica in Revista Enfermagem Contemporânea
- Vol. 12, e5162
Análise da prescrição medicamentosa dos idosos atendidos em um ambulatório de geriatria
OBJETIVO: Avaliar a prescrição medicamentosa dos idosos atendidos em um ambulatório geriátrico baseado Consenso Brasileiro de Medicamentos Potencialmente Inapropriados para Idosos (MPI). METODOLOGIA: Trata-se de uma pesquisa descritiva com análise retrospectiva do prontuário eletrônico de pacientes com idade igual ou superior a 60 anos, atendidos no ambulatório geriátrico de um hospital baiano no período de janeiro a junho de 2018. Foram incluídos 291 prontuários e coletados os medicamentos que o idoso já fazia uso em seu domicílio e a prescrição vigente após a consulta. RESULTADOS: A idade mediana foi de 73 anos. Foi identificado que antes da consulta 89 idosos (30,6%) faziam uso de MPI e que após a consulta com geriatra 110 idosos (37,6%) passaram a utilizá-los, sem diferença estatística. A mediana de números de medicamentos posteriores à consulta ambulatorial foi maior do que anterior à consulta, com significância estatística (pCONCLUSÃO: Mesmo após a consulta com o geriatra ainda existem inadequações nas prescrições, com um número relevante de idosos utilizando cinco ou mais medicamentos e em uso de MPI.
- 4 July 2023
- Published by Escola Bahiana de Medicina e Saude Publica in Revista Enfermagem Contemporânea
- Vol. 12, e5162
Open AccessAnálise da prescrição medicamentosa dos idosos atendidos em um ambulatório de geriatria
OBJETIVO: Avaliar a prescrição medicamentosa dos idosos atendidos em um ambulatório geriátrico baseado Consenso Brasileiro de Medicamentos Potencialmente Inapropriados para Idosos (MPI). METODOLOGIA: Trata-se de uma pesquisa descritiva com análise retrospectiva do prontuário eletrônico de pacientes com idade igual ou superior a 60 anos, atendidos no ambulatório geriátrico de um hospital baiano no período de janeiro a junho de 2018. Foram incluídos 291 prontuários e coletados os medicamentos que o idoso já fazia uso em seu domicílio e a prescrição vigente após a consulta. RESULTADOS: A idade mediana foi de 73 anos. Foi identificado que antes da consulta 89 idosos (30,6%) faziam uso de MPI e que após a consulta com geriatra 110 idosos (37,6%) passaram a utilizá-los, sem diferença estatística. A mediana de números de medicamentos posteriores à consulta ambulatorial foi maior do que anterior à consulta, com significância estatística (pCONCLUSÃO: Mesmo após a consulta com o geriatra ainda existem inadequações nas prescrições, com um número relevante de idosos utilizando cinco ou mais medicamentos e em uso de MPI.